105 related articles for article (PubMed ID: 10520641)
1. Association of CCR5 delta32 with reduced risk of asthma.
Hall IP; Wheatley A; Christie G; McDougall C; Hubbard R; Helms PJ
Lancet; 1999 Oct; 354(9186):1264-5. PubMed ID: 10520641
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of CCR5-delta32 mutation in asthmatic and non-asthmatic subjects from department of medicine, JUCM, Cracow.
Gomulska M; Rusin G; Gwiazdak P
Folia Med Cracov; 2014; 54(4):5-13. PubMed ID: 25891238
[TBL] [Abstract][Full Text] [Related]
3. Association of CCR5-delta32 mutation with reduced risk of nonatopic asthma in Slovenian children.
Berce V; Repnik K; Potocnik U
J Asthma; 2008 Nov; 45(9):780-4. PubMed ID: 18972295
[TBL] [Abstract][Full Text] [Related]
4. Lack of association between chemokine receptor 5 (CCR5) δ32 mutation and pathogenesis of asthma in Iranian patients.
Abousaidi H; Vazirinejad R; Arababadi MK; Rafatpanah H; Pourfathollah AA; Derakhshan R; Daneshmandi S; Hassanshahi G
South Med J; 2011 Jun; 104(6):422-5. PubMed ID: 21886032
[TBL] [Abstract][Full Text] [Related]
5. Further support for the association of CCR5 allelic variants with asthma susceptibility.
McGinnis R; Child F; Clayton S; Davies S; Lenney W; Illig T; Wjst M; Spurr N; Debouck C; Hajeer AH; Ollier WE; Strange R; Fryer AA
Eur J Immunogenet; 2002 Dec; 29(6):525-8. PubMed ID: 12437612
[TBL] [Abstract][Full Text] [Related]
6. Delta 32 deletion of CCR5 gene and association with asthma or atopy.
Mitchell TJ; Walley AJ; Pease JE; Venables PJ; Wiltshire S; Williams TJ; Cookson WO
Lancet; 2000 Oct; 356(9240):1491-2. PubMed ID: 11081537
[TBL] [Abstract][Full Text] [Related]
7. Protective effect of CCR5-Δ32 against HIV infection by the heterosexual mode of transmission in a Polish population.
Zwolińska K; Knysz B; Rybka K; Pazgan-Simon M; Gąsiorowski J; Sobczyński M; Gładysz A; Piasecki E
AIDS Res Hum Retroviruses; 2013 Jan; 29(1):54-60. PubMed ID: 22957692
[TBL] [Abstract][Full Text] [Related]
8. The chemokine receptor 5 Delta32 mutation is associated with increased renal survival in patients with IgA nephropathy.
Panzer U; Schneider A; Steinmetz OM; Wenzel U; Barth P; Reinking R; Becker JU; Harendza S; Zahner G; Fischereder M; Krämer BK; Schlöndorff D; Ostendorf T; Floege J; Helmchen U; Stahl RA
Kidney Int; 2005 Jan; 67(1):75-81. PubMed ID: 15610230
[TBL] [Abstract][Full Text] [Related]
9. The prevalence of CCR5-Δ32 mutation in a cohort of Saudi stem cell donors.
Alarifi M; Al-Amro F; Alalwan A; Al-Turki A; Fakhoury H; Atallah N; Al-Muallimi M; Al-Balwi M; Alzahrani M; Alaskar A; Hajeer A; Jawdat D
HLA; 2017 Nov; 90(5):292-294. PubMed ID: 28731615
[TBL] [Abstract][Full Text] [Related]
10. Distribution of the mutated delta 32 allele of the CCR5 gene in a Sicilian population.
Sidoti A; D'Angelo R; Rinaldi C; De Luca G; Pino F; Salpietro C; Giunta DE; Saltalamacchia F; Amato A
Int J Immunogenet; 2005 Jun; 32(3):193-8. PubMed ID: 15932625
[TBL] [Abstract][Full Text] [Related]
11. The chemokine receptor CCR5-Delta32 gene mutation is not protective against Alzheimer's disease.
Combarros O; Infante J; Llorca J; Peña N; Fernández-Viadero C; Berciano J
Neurosci Lett; 2004 Aug; 366(3):312-4. PubMed ID: 15288441
[TBL] [Abstract][Full Text] [Related]
12. Chemokine receptor 5 (CCR5) deletion polymorphism in North Indian patients with coronary artery disease.
Sharda S; Gilmour A; Harris V; Singh VP; Sinha N; Tewari S; Ramesh V; Agrawal S; Mastana S
Int J Cardiol; 2008 Feb; 124(2):254-8. PubMed ID: 17383752
[TBL] [Abstract][Full Text] [Related]
13. CC-type chemokine receptor 5-Delta32 mutation protects against primary sclerosing cholangitis.
Henckaerts L; Fevery J; Van Steenbergen W; Verslype C; Yap P; Nevens F; Roskams T; Libbrecht L; Rutgeerts P; Vermeire S
Inflamm Bowel Dis; 2006 Apr; 12(4):272-7. PubMed ID: 16633049
[TBL] [Abstract][Full Text] [Related]
14. Increase in CCR5 Delta32/Delta32 genotype in multiple sclerosis.
Pulkkinen K; Luomala M; Kuusisto H; Lehtimäki T; Saarela M; Jalonen TO; Elovaara I
Acta Neurol Scand; 2004 May; 109(5):342-7. PubMed ID: 15080861
[TBL] [Abstract][Full Text] [Related]
15. Analysis of the CC chemokine receptor 5 delta32 polymorphism in a Brazilian population with cutaneous leishmaniasis.
Brajão de Oliveira K; Reiche EM; Kaminami Morimoto H; Pelegrinelli Fungaro MH; Estevão D; Pontello R; Franco Nasser T; Watanabe MA
J Cutan Pathol; 2007 Jan; 34(1):27-32. PubMed ID: 17214851
[TBL] [Abstract][Full Text] [Related]
16. Distribution of the HIV resistance CCR5-Delta32 allele among Egyptians and Syrians.
Salem AH; Batzer MA
Mutat Res; 2007 Mar; 616(1-2):175-80. PubMed ID: 17166523
[TBL] [Abstract][Full Text] [Related]
17. Frequency of CCR5-Delta32 deletion in human immunodeficiency virus type 1 (HIV-1) in healthy blood donors, HIV-1-exposed seronegative and HIV-1-seropositive individuals of southern Brazilian population.
Reiche EM; Ehara Watanabe MA; Bonametti AM; Morimoto HK; Akira Morimoto A; Wiechmann SL; Matsuo T; Carvalho De Oliveira J; Vissoci Reiche F
Int J Mol Med; 2008 Nov; 22(5):669-75. PubMed ID: 18949389
[TBL] [Abstract][Full Text] [Related]
18. Frequencies of gene variant CCR5-Δ32 in 87 countries based on next-generation sequencing of 1.3 million individuals sampled from 3 national DKMS donor centers.
Solloch UV; Lang K; Lange V; Böhme I; Schmidt AH; Sauter J
Hum Immunol; 2017 Nov; 78(11-12):710-717. PubMed ID: 28987960
[TBL] [Abstract][Full Text] [Related]
19. The role of the CCR5 Delta32 polymorphism in abdominal aortic aneurysms.
Sandford B; Bown M; London N; Sayers R
Int J Immunogenet; 2009 Aug; 36(4):199-205. PubMed ID: 19476483
[TBL] [Abstract][Full Text] [Related]
20. The role of the C-C chemokine receptor-5 Delta32 polymorphism in asthma and in the production of regulated on activation, normal T cells expressed and secreted.
Sandford AJ; Zhu S; Bai TR; Fitzgerald JM; Paré PD
J Allergy Clin Immunol; 2001 Jul; 108(1):69-73. PubMed ID: 11447384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
